1University of Melbourne. Austin and Repatriation Medical Centre, Heidelberg, Victoria, Australia.
Selective estrogen receptor modulator raloxifene significantly reduces spine fractures and breast cancer risk in postmenopausal women. It also lowers cholesterol but carries a small risk of thromboembolic events.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: